Media Release 30 October 2026 Quarterly Shareholder Report | September 2026 Syntara Limited (ASX: SNT), a clinical-stage drug development company, is pleased to provide a summary of its activities for the quarter ended 30 September 2026: • Preliminary Phase 2 SNT-4728 results demonstrate a...